CMS approves ADLT status for Guardant Health’s Shield test, setting Medicare reimbursement at $1,495. The analyst sees a potential revenue boost from the decision.
Latest Ratings for GH
DateFirmActionFromTo Feb 2022Wells FargoMaintainsOverweight Feb 2022Morgan StanleyMaintainsOverweight Feb 2022CitigroupMaintainsBuy